A first-ever effective therapy for rare devastating neurodegenerative diseases

With the support of a nonprofit organization started by a patient’s family, rare disease expert Dr. Kenneth Myers initiated a clinical trial for...
July 31, 2024

A protective mechanism against spinocerebellar ataxia

DNA sequence prevents genetic variations from expanding and causing disease   A recent study published in Nature Genetics led by Dr. Bernard Brais...
July 31, 2024

The BigBrain: Mapping the future of neuroscience

Researchers are working to improve on the acclaimed 3D digital atlas of the brain they introduced a decade ago   A decade after...
July 31, 2024

Triple-negative breast cancer: new hope for an existing drug

RI-MUHC team takes another step toward precision medicine by targeting a biomarker of CDK4/6 inhibitor efficacy in breast cancer, including triple-negative breast cancer...
July 30, 2024

101 McGill research projects awarded $23.5 million in NSERC Discovery Grants funding

Funding supports groundbreaking research in the natural sciences and engineering   The Natural Sciences and Engineering Research Council of Canada (NSERC) has awarded...
July 30, 2024

A modernized Clinical Trials Network to tackle health challenges associated with HIV and other sexually transmitted and blood-borne infections in Canada

Dr. Marina Klein will lead the network at the Research Institute of the McGill University Health Centre. Globally and in Canada, new cases...
July 30, 2024

Prescribing personalized lifestyle interventions to improve prostate cancer treatments

David Labbé of the RI-MUHC co-leads a new project recently funded by the Marathon of Hope Cancer Centres Network   In recent years,...
July 29, 2024

Study sheds light on origins of schizophrenia in the brain, offering hope for targeted treatments and better diagnosis

Routine MRI scans could revolutionize the way we diagnose and treat schizophrenia, improving outcomes for those affected, researchers say   A group of...
July 29, 2024

Researchers find a possible therapeutic target in the “genetic landscape” of aggressive and deadly pediatric brain tumours

A new study reveals that PFA ependymoma brain tumours display unique 3D genome features that could be exploited therapeutically   Posterior fossa group...
July 16, 2024

Systemic sclerosis is on the rise in Quebec, especially in children, study finds

While mortality rates for the autoimmune disease have declined, uneven geographic distribution of cases points to need for tailored interventions, further research  ...
July 16, 2024

Defining genetic discrimination: toward equity in healthcare and research

A proposed definition of "genetic discrimination" aims to unify discussions and policies in healthcare and research, and address discrimination in genetic research.  ...
July 11, 2024

Increasing clinical trial expertise at the RI-MUHC

The RI-MUHC ACT-CTU reports on the realization of its vision for 2024 to build a clinical trials community and strengthen trial capabilities at...
July 11, 2024